SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 81 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $34,714,931 | -45.5% | 6,358,046 | -0.2% | 0.00% | -33.3% |
Q1 2024 | $63,701,650 | +164.2% | 6,370,165 | +7.8% | 0.00% | +200.0% |
Q4 2023 | $24,107,443 | +35.2% | 5,908,687 | +28.2% | 0.00% | 0.0% |
Q3 2023 | $17,834,868 | -38.1% | 4,608,493 | -4.7% | 0.00% | -50.0% |
Q2 2023 | $28,833,306 | +54.9% | 4,837,803 | -15.0% | 0.00% | +100.0% |
Q1 2023 | $18,617,353 | -65.3% | 5,693,380 | -58.1% | 0.00% | -50.0% |
Q4 2022 | $53,631,132 | +36.5% | 13,577,502 | +107.4% | 0.00% | 0.0% |
Q3 2022 | $39,288,000 | -28.9% | 6,548,082 | -23.8% | 0.00% | -33.3% |
Q2 2022 | $55,262,000 | -6.4% | 8,594,413 | +20.2% | 0.00% | 0.0% |
Q1 2022 | $59,067,000 | +7.9% | 7,150,930 | +102.2% | 0.00% | 0.0% |
Q4 2021 | $54,743,000 | -8.5% | 3,536,339 | +33.1% | 0.00% | 0.0% |
Q3 2021 | $59,825,000 | +54.0% | 2,656,510 | +34.4% | 0.00% | +50.0% |
Q2 2021 | $38,857,000 | +449.8% | 1,976,442 | +836.0% | 0.00% | – |
Q1 2021 | $7,068,000 | – | 211,161 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trustees of Columbia University in the City of New York | 281,250 | $6,334,000 | 9.69% |
Flagship Pioneering Inc. | 34,239,018 | $771,063,000 | 8.08% |
Crestline Management, LP | 3,210,937 | $72,310,000 | 6.80% |
SB Management Ltd | 2,209,004 | $49,747,000 | 5.10% |
Omega Fund Management, LLC | 843,750 | $19,001,000 | 2.13% |
HARVARD MANAGEMENT CO INC | 1,163,601 | $26,204,000 | 1.54% |
Alphabet Inc. | 2,812,500 | $63,338,000 | 1.50% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 387,508 | $8,727,000 | 1.03% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $93,036,000 | 0.53% |
Dragoneer Investment Group | 1,500,000 | $33,780,000 | 0.44% |